Apozem Naturals Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.00 Cr
as on 01-07-2024
- Satisfied Charges ₹ 1.00 Cr
as on 01-07-2024
- Revenue -81.26%
(FY 2020)
- Profit 25.77%
(FY 2020)
- Ebitda 22.16%
(FY 2020)
- Net Worth -69.44%
(FY 2020)
- Total Assets -86.62%
(FY 2020)
About Apozem Naturals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kommini Chowdhary, Chinna Rajababu, Bathala Chowdary, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC108094
- Company No.
108094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Apozem Naturals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kommini Chowdhary  | Director | 22-Nov-2017 | Current |
| Chinna Rajababu | Director | 22-Nov-2017 | Current |
| Bathala Chowdary | Director | 22-Nov-2017 | Current |
| Bharath Shivashankara | Director | 05-Jun-2018 | Current |
Financial Performance of Apozem Naturals.
Apozem Naturals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 81.26% decrease. The company also saw a substantial improvement in profitability, with a 25.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 69.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apozem Naturals?
In 2019, Apozem Naturals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uravi Projects LlpActive 1 year 6 monthsKommini Chowdhary and Bharath Shivashankara are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Jul 2018 | ₹1.00 Cr | Open |
Others Creation Date: 21 May 2018 | ₹2.00 Cr | Open |
Others Creation Date: 04 Apr 2018 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Apozem Naturals?
Unlock and access historical data on people associated with Apozem Naturals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apozem Naturals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apozem Naturals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
